Guido Tricot

Guido Tricot

UNVERIFIED PROFILE

Are you Guido Tricot?   Register this Author

Register author
Guido Tricot

Guido Tricot

Publications by authors named "Guido Tricot"

Are you Guido Tricot?   Register this Author

100Publications

2740Reads

26Profile Views

A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma.

Cell Transplant 2019 Oct 16:963689719880541. Epub 2019 Oct 16.

Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0963689719880541DOI Listing
October 2019

Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.

J Natl Cancer Inst 2019 Aug 12. Epub 2019 Aug 12.

Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djz159DOI Listing
August 2019

Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia.

Clin Cancer Res 2019 01 2;25(1):201-209. Epub 2018 Oct 2.

Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1435DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320275PMC
January 2019

Bloodless tandem autologous transplant in Jehovah's Witness patients.

Bone Marrow Transplant 2018 11 24;53(11):1428-1433. Epub 2018 May 24.

Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0132-6DOI Listing
November 2018

Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.

BMC Cancer 2018 Nov 21;18(1):1152. Epub 2018 Nov 21.

Department of Pathology, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa, 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-5015-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249818PMC
November 2018

Toxoplasma Encephalitis following Tandem Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature.

Case Rep Infect Dis 2018 11;2018:9409121. Epub 2018 Nov 11.

University of Iowa, Department of Internal Medicine, Division of Infectious Diseases, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/9409121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252224PMC
November 2018

Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome.

Blood Cancer J 2018 02 15;8(2):22. Epub 2018 Feb 15.

Department of Pathology, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, 52242, Iowa, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0060-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814454PMC
February 2018

Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma.

Oncotarget 2017 Dec 27;8(67):111213-111224. Epub 2017 Nov 27.

Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22740DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762316PMC
December 2017

Drug Combinations with Transplantation for Myeloma.

N Engl J Med 2017 07;377(1):91-2

University of Iowa Hospitals and Clinics, Iowa City, IA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1705671DOI Listing
July 2017

Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid.

EBioMedicine 2017 Apr 16;18:41-49. Epub 2017 Feb 16.

Department of Medicine, Division of Hematology, Oncology and Blood and Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2017.02.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405162PMC
April 2017

NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase.

J Hematol Oncol 2017 01 13;10(1):17. Epub 2017 Jan 13.

Department of Medicine, Division of Hematology, Oncology and Blood and Marrow Transplantation and Holden Comprehensive Cancer Center, University of Iowa, 585 Newton Rd, 52242, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-017-0392-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237262PMC
January 2017

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma.

Onco Targets Ther 2017 6;10:217-226. Epub 2017 Jan 6.

Holden Comprehensive Cancer Center; Department of Internal Medicine, Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S112423DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5229169PMC
January 2017

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Authors:
Kristin A Rand Chi Song Eric Dean Daniel J Serie Karen Curtin Xin Sheng Donglei Hu Carol Ann Huff Leon Bernal-Mizrachi Michael H Tomasson Sikander Ailawadhi Seema Singhal Karen Pawlish Edward S Peters Cathryn H Bock Alex Stram David J Van Den Berg Christopher K Edlund David V Conti Todd Zimmerman Amie E Hwang Scott Huntsman John Graff Ajay Nooka Yinfei Kong Silvana L Pregja Sonja I Berndt William J Blot John Carpten Graham Casey Lisa Chu W Ryan Diver Victoria L Stevens Michael R Lieber Phyllis J Goodman Anselm J M Hennis Ann W Hsing Jayesh Mehta Rick A Kittles Suzanne Kolb Eric A Klein Cristina Leske Adam B Murphy Barbara Nemesure Christine Neslund-Dudas Sara S Strom Ravi Vij Benjamin A Rybicki Janet L Stanford Lisa B Signorello John S Witte Christine B Ambrosone Parveen Bhatti Esther M John Leslie Bernstein Wei Zheng Andrew F Olshan Jennifer J Hu Regina G Ziegler Sarah J Nyante Elisa V Bandera Brenda M Birmann Sue A Ingles Michael F Press Djordje Atanackovic Martha J Glenn Lisa A Cannon-Albright Brandt Jones Guido Tricot Thomas G Martin Shaji K Kumar Jeffrey L Wolf Sandra L Deming Halverson Nathaniel Rothman Angela R Brooks-Wilson S Vincent Rajkumar Laurence N Kolonel Stephen J Chanock Susan L Slager Richard K Severson Nalini Janakiraman Howard R Terebelo Elizabeth E Brown Anneclaire J De Roos Ann F Mohrbacher Graham A Colditz Graham G Giles John J Spinelli Brian C Chiu Nikhil C Munshi Kenneth C Anderson Joan Levy Jeffrey A Zonder Robert Z Orlowski Sagar Lonial Nicola J Camp Celine M Vachon Elad Ziv Daniel O Stram Dennis J Hazelett Christopher A Haiman Wendy Cozen

Cancer Epidemiol Biomarkers Prev 2016 12 1;25(12):1609-1618. Epub 2016 Sep 1.

Keck School of Medicine of USC and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-1193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524541PMC
December 2016

Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma.

Br J Haematol 2016 08 12;174(4):536-40. Epub 2016 May 12.

Division of Hematology/Oncology and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14081DOI Listing
August 2016

Reply.

Inflamm Bowel Dis 2016 08;22(8):E27-8

*Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA†Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Medical Center, University of Minnesota, Minneapolis, MN‡Division of Infectious Diseases, Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA§Division of Hematology, Oncology and Bone Marrow Transplantation, Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA||Department of Veterinary Microbiology, Iowa State University, Ames, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000861DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170004PMC
August 2016

Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation.

Inflamm Bowel Dis 2016 01;22(1):194-201

*Division of Gastroenterology and Hepatology, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa; †Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Medical Center, University of Minnesota, Minneapolis, Minnesota; ‡Division of Infectious Diseases, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa; §Division of Hematology, Oncology and Bone Marrow Transplantation, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa; and ‖Department of Veterinary Microbiology, Iowa State University, Ames, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000599DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679592PMC
January 2016

A Pooled Analysis of Reproductive Factors, Exogenous Hormone Use, and Risk of Multiple Myeloma among Women in the International Multiple Myeloma Consortium.

Cancer Epidemiol Biomarkers Prev 2016 Jan 13;25(1):217-21. Epub 2015 Oct 13.

Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Barcelona, Spain. Department of Medicine, University of Barcelona, Barcelona, Spain. CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745255PMC
January 2016

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.

Oncotarget 2016 Jan;7(2):1598-607

Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811483PMC
January 2016

NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.

Clin Cancer Res 2015 Dec 8;21(24):5532-42. Epub 2015 Jul 8.

Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0254DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804624PMC
December 2015

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?

Oncotarget 2015 Dec;6(38):40496-506

Department of Internal Medicine, The University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.5800DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747348PMC
December 2015

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus.

Oncotarget 2015 Dec;6(38):41275-89

Department of Medicine and The Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center, San Antonio, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.5753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747405PMC
December 2015

Inhibition of Nek2 by small molecules affects proteasome activity.

Biomed Res Int 2014 17;2014:273180. Epub 2014 Sep 17.

Tolero Pharmaceuticals Inc., 2975 Executive Parkway, Suite 320, Lehi, UT 84043, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/273180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182079PMC
July 2015

Nek2 is a novel regulator of B cell development and immunological response.

Biomed Res Int 2014 17;2014:621082. Epub 2014 Nov 17.

Department of Internal Medicine, University of Iowa City, Carver College of Medicine, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/621082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251609PMC
July 2015

Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation.

Cancer Res 2015 Jun 8;75(11):2211-21. Epub 2015 Apr 8.

Department of Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa City, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-3804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946247PMC
June 2015

Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients.

J Clin Apher 2015 Feb 19;30(1):1-7. Epub 2014 Jun 19.

Department of Medicine, Division of Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jca.21341DOI Listing
February 2015

Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma.

Cancer Res 2015 Feb 14;75(3):594-604. Epub 2015 Jan 14.

Department of Internal Medicine, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa. Interdisciplinary Program in Molecular and Cellular Biology, University of Iowa, Iowa City, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-2362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384656PMC
February 2015

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.

Oncotarget 2014 Dec;5(23):11986-97

Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, United States.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322982PMC
http://dx.doi.org/10.18632/oncotarget.2388DOI Listing
December 2014

Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.

Immunol Res 2014 Aug;59(1-3):188-202

Interdisciplinary Graduate Program in Immunology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12026-014-8528-x
Publisher Site
http://dx.doi.org/10.1007/s12026-014-8528-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209159PMC
August 2014

Parathyroid hormone receptor mediates the anti-myeloma effect of proteasome inhibitors.

Bone 2014 Apr 31;61:39-43. Epub 2013 Dec 31.

Department of Orthopaedic Surgery, Center for Orthopaedic Research, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2013.12.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967551PMC
April 2014

RARα2 expression confers myeloma stem cell features.

Blood 2013 Aug 11;122(8):1437-47. Epub 2013 Jul 11.

Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-02-482919DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750340PMC
August 2013

Impact of bortezomib on bone health in myeloma: a review of current evidence.

Cancer Treat Rev 2012 Dec 9;38(8):968-80. Epub 2012 Jan 9.

Stem Cell Transplant and Myeloma Program, University of Utah, UT 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2011.12.007DOI Listing
December 2012

Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation.

Biol Blood Marrow Transplant 2012 Nov 19;18(11):1753-8. Epub 2012 Jun 19.

Division of Infectious Diseases, Department of Internal Medicine, University of Utah, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.06.008DOI Listing
November 2012

Mechanisms of thrombosis in paraproteinemias: the effects of immunomodulatory drugs.

Semin Thromb Hemost 2012 Nov 28;38(8):768-79. Epub 2012 Oct 28.

Myeloma Program, Division of Hematology, University of Utah, Salt Lake City, 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0032-1328888DOI Listing
November 2012

Progress in myeloma stem cells.

Am J Blood Res 2011 8;1(2):135-45. Epub 2011 Sep 8.

Division of Hematology, Blood/Marrow Transplant and Myeloma Program 30 N 1900 E, 5C417, University of Utah, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301427PMC
August 2012

Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens.

Clin Lymphoma Myeloma Leuk 2011 Apr 8;11(2):228-36. Epub 2011 Apr 8.

Blood/Marrow Transplant and Myeloma Program, Division of Hematology, University of Utah, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.03.006DOI Listing
April 2011

Comparison of unmobilized and mobilized graft characteristics and the implications of cell subsets on autologous and allogeneic transplantation outcomes.

Biol Blood Marrow Transplant 2010 Dec 7;16(12):1629-48. Epub 2010 Feb 7.

Center for Tumor Diagnostics and Therapy, Paracelsus Klinik, Am Natruper Holz 69, Osnabrück, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.02.002DOI Listing
December 2010

Evolving indications for hematopoietic stem cell transplantation in multiple myeloma and other plasma cell disorders.

Cancer Treat Res 2009 ;144:317-55

University of Utah School of Medicine, Salt Lake City, UT, USA. Guido.Tricot@ hsc.utah.edu

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-0-387-78580-6_14
Publisher Site
http://dx.doi.org/10.1007/978-0-387-78580-6_14DOI Listing
September 2010

Bone and paraproteinemias.

Curr Opin Support Palliat Care 2010 Sep;4(3):195-9

University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=01263393-201009000-000
Publisher Site
http://dx.doi.org/10.1097/SPC.0b013e32833d3011DOI Listing
September 2010

Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone.

J Clin Oncol 2010 Jan 9;28(1):132-5. Epub 2009 Nov 9.

Division of Hematology, Blood/Marrow Transplant and Myeloma Program, 30 N 1900 E, 5C402, University of Utah, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.23.0169DOI Listing
January 2010

Thrombotic events in patients with cancer receiving antiangiogenesis agents.

J Clin Oncol 2009 Oct 24;27(29):4865-73. Epub 2009 Aug 24.

University of Utah, Division of Hematology, Blood/Marrow Transplant and Myeloma Program, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.22.3875
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.22.3875DOI Listing
October 2009

Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.

Blood Coagul Fibrinolysis 2009 Jul;20(5):337-9

Division of Hematology-Oncology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e32832b27e6DOI Listing
July 2009

RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma.

Blood 2009 Jul 20;114(3):600-7. Epub 2009 May 20.

The Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics at the Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 W Markham, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-12-194126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713470PMC
July 2009

Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy.

Haematologica 2008 Nov 25;93(11):1739-42. Epub 2008 Aug 25.

University of Utah School of Medicine, 30N 1900E, 5C402,Salt Lake City, UT 84132 USA.

View Article

Download full-text PDF

Source
http://www.haematologica.org/cgi/doi/10.3324/haematol.13204
Publisher Site
http://dx.doi.org/10.3324/haematol.13204DOI Listing
November 2008

Is more better in myeloma?

Authors:
Guido Tricot

Blood 2008 Nov;112(9):3532

University of Utah School of Medicine, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-06-163782DOI Listing
November 2008

High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.

Cancer 2008 Apr;112(8):1754-64

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652244PMC
April 2008

Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myeloma.

J Immunother 2007 Nov-Dec;30(8):847-54

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e318158fcffDOI Listing
January 2008

Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients.

Blood Coagul Fibrinolysis 2007 Oct;18(7):595-8

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e3281067fb2DOI Listing
October 2007

Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients.

Am J Hematol 2007 Sep;82(9):831-3

The Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.20961DOI Listing
September 2007

Hemostatic dysfunction in paraproteinemias and amyloidosis.

Semin Thromb Hemost 2007 Jun;33(4):339-49

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2007-976169DOI Listing
June 2007

Thrombosis in multiple myeloma.

Expert Rev Anticancer Ther 2007 Mar;7(3):307-15

Myeloma Institute, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Slot 776, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.7.3.307DOI Listing
March 2007

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.

Blood 2007 Feb 5;109(4):1692-700. Epub 2006 Oct 5.

Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-07-037077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794073PMC
February 2007

What is the significance of molecular remission in multiple myeloma?

Authors:
Guido J Tricot

Clin Adv Hematol Oncol 2007 Feb;5(2):91-5

Clinical Research in the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
February 2007

High-dose therapy in patients with plasma cell dyscrasias and renal dysfunction.

Contrib Nephrol 2007 ;153:182-94

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000096767DOI Listing
January 2007

Targeting signaling pathways in multiple myeloma.

Curr Pharm Biotechnol 2006 Dec;7(6):407-13

Divisione di Ematologia dell Universita di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138920106779116883DOI Listing
December 2006

Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myeloma.

Curr Pharm Biotechnol 2006 Dec;7(6):449-53

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138920106779116838DOI Listing
December 2006

NY-ESO-1 immunotherapy for multiple myeloma.

Leuk Lymphoma 2006 Oct;47(10):2037-48

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600742292DOI Listing
October 2006

Response to bortezomib and activation of osteoblasts in multiple myeloma.

Clin Lymphoma Myeloma 2006 Sep;7(2):109-14

University of Arkansas for Medical Sciences, Little Rock , AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.047DOI Listing
September 2006

Clinical and biological features of multiple myeloma involving the gastrointestinal system.

Haematologica 2006 Jul;91(7):964-7

Myeloma Institute for Research and Therapy, Division of Gastroenterology, The University of Arkansas for Medical Sciences, 4301 West Markham Street/Slot 776, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
July 2006

Tandem transplants in the treatment of multiple myeloma. Pro.

Clin Adv Hematol Oncol 2004 May;2(5):303-4

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
May 2004